Recent developments in application of precision medicine to cancer treatment support the application of epigenetic restoration of STAT6 via DNA methyltransferase inhibitors (DNMTi) as a therapeutic strategy for STAT6-silenced gliomas. This evidence concerns the gene STAT6 and central nervous system cancer.